A Sequential Two-Step Cell-Based Assay Predicts Immunosuppression-Related Adverse Events.
J Immunol. 2020 Dec 15;205(12):3291-3299. doi: 10.4049/jimmunol.2000782. Epub 2020 Nov 13.
J Immunol. 2020.
PMID: 33188075
Free article.
Clinical Trial.